marginally significantp < 0.1
Differences in gut microbiota between healthy controls and IBS subjects were significant in 9 out of 13 cohorts ( p < 0.05, PERMANOVA, Figure 2c ), with two additional cohorts marginally significant ( p < 0.1).
Differences in gut microbiota between healthy controls and IBS subjects were significant in 9 out of 13 cohorts ( p < 0.05, PERMANOVA, Figure 2c ), with two additional cohorts marginally significant ( p < 0.1).